ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

FOSAMAX ORAL SOLUTION
Bone disorders
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

REMOVE SELECTED | COMPARE SELECTED

Drug Name:

FOSAMAX ORAL SOLUTION Rx

Generic Name and Formulations:
Alendronate (as sodium) 70mg/75mL; raspberry flavor; contain parabens.

Company:
Merck & Co., Inc.

e-Prescribe this drug via Surescripts


Therapeutic Use:

Product Resources »
  • Product Information
  • Coupons, Samples & Vouchers
  • Patient Education and Assistance

Indications for FOSAMAX ORAL SOLUTION:

Treatment of postmenopausal osteoporosis. Treatment of osteoporosis in men.

Adult Dose for FOSAMAX ORAL SOLUTION:

Swallow whole. Take in the AM with plain (not mineral) water only, at least 30 minutes before the first food, drink, or medication of the day (6–8oz water after tabs or 2oz after oral solution); do not lie down for at least 30 minutes and until after the first food of the day. Osteoporosis treatment in men or postmenopausal women: 10mg tab once daily or 70mg once weekly or one 70mg/2800 IU or 70mg/5600 IU tab once weekly. Osteoporosis prevention in postmenopausal women: 5mg tab once daily or 35mg tab once weekly. Glucocorticoid-induced: 5mg tab once daily; glucocorticoid-induced in postmenopausal women not on estrogen: 10mg tab once daily. Paget's: 40mg once daily for 6 months; may retreat after a 6-month post-treatment evaluation period (based on serum alkaline phosphatase).

Children's Dose for FOSAMAX ORAL SOLUTION:

Not recommended.

See Also:

FOSAMAX

FOSAMAX PLUS D

Pharmacological Class:

Bisphosphonate.

Contraindications:

Esophageal abnormalities which delay esophageal emptying (eg, stricture, achalasia). Inability to stand or sit upright for at least 30 minutes. Aspiration risk (oral solution). Hypocalcemia.

Warnings/Precautions:

Active upper GI disease; discontinue and reevaluate if signs/symptoms of esophageal reaction occur. Severe renal insufficiency (CrCl <35mL/min): not recommended. Correct preexisting hypocalcemia, other mineral (eg, Vit. D deficiency) or bone disturbances before starting. Monitor for hypocalcemia during therapy. Ensure adequate Vit. D and calcium intake. Consider discontinuing therapy during invasive dental procedures (eg, tooth extraction, implants, surgery). History of bisphosphonate exposure: evaluate for atypical fractures if thigh/groin pain develops; consider withholding therapy until risk/benefit assessment. Reevaluate periodically. Fosamax Plus D: not for sole treatment of Vit. D deficiency. Pregnancy (Cat.C). Nursing mothers.

Interactions:

Calcium supplements, antacids, other multivalent cations reduce absorption (separate dosing by at least 30min). Increased GI distress with aspirin and alendronate >10mg/day; caution with NSAIDs, other GI irritants. Anticonvulsants, cimetidine, thiazides, olestra, mineral oils, orlistat, bile acid sequestrants may antagonize Vit. D3.

Adverse Reactions:

GI upset, abdominal pain, acid regurgitation, musculoskeletal pain (may be severe), headache, esophagitis; esophageal ulcer, stricture, or erosion, melena; jaw osteonecrosis, atypical femur fractures; rarely: gastric or duodenal ulcer.

How Supplied:

Tabs 5mg—30, 100; 10mg—30, 100, 1000; 35mg, 70mg—4; 40mg—30; Soln—4 X 75mL; Plus D—4